• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

剖析泛素化在p53信号通路中的作用。

Dissecting roles of ubiquitination in the p53 pathway.

作者信息

Shan J, Brooks C, Kon N, Li M, Gu W

机构信息

Institute for Cancer Genetics and Department of Pathology and Cell Biology, College of Physicians and Surgeons, Columbia University 1130 St. Nicholas Ave, New York, NY 10032, USA.

出版信息

Ernst Schering Found Symp Proc. 2008(1):127-36. doi: 10.1007/2789_2008_105.

DOI:10.1007/2789_2008_105
PMID:19202598
Abstract

Posttranslational modification of proteins by mono- or polyubiquitination represents a central mechanism to modulate a wide range of cellular functions like protein stability, intracellular transport, protein interactions, and transcriptional activity. Analogous to other posttranslational modifications, ubiquitination is a reversible process counteracted by deubiquitinating enzymes (DUBs), which cleave the isopeptide linkage between protein substrate and the ubiquitin residue. The p53 tumor suppressor is a sequence-specific DNA-binding transcriptional factor that plays a central role in regulating growth arrest and apoptosis during the stress response. Notably, recent studies indicate that both the stability and the subcellular localization of p53 are tightly regulated by ubiquitination; p53 is mainly ubiquitinated by Mdm2 but other ubiquitin ligases such as ARF-BP1/HectH9/MULE are also involved in p53 regulation in vivo. Moreover, a deubiquitinase HAUSP was initially identified in p53 deubiquitination but more recent studies showed that both Mdm2 and Mdmx are also bona fide substrates of HAUSP. In this article, we review our latest understanding of ubiquitination in modulating the p53 tumor suppression pathway.

摘要

蛋白质的单泛素化或多泛素化修饰是调节多种细胞功能(如蛋白质稳定性、细胞内运输、蛋白质相互作用和转录活性)的核心机制。与其他翻译后修饰类似,泛素化是一个可逆过程,去泛素化酶(DUBs)可抵消该过程,去泛素化酶能切割蛋白质底物与泛素残基之间的异肽键。p53肿瘤抑制因子是一种序列特异性DNA结合转录因子,在应激反应过程中调节生长停滞和细胞凋亡方面发挥核心作用。值得注意的是,最近的研究表明,p53的稳定性和亚细胞定位均受到泛素化的严格调控;p53主要被Mdm2泛素化,但其他泛素连接酶如ARF-BP1/HectH9/MULE在体内也参与p53的调控。此外,去泛素化酶HAUSP最初是在p53去泛素化过程中被鉴定出来的,但最近的研究表明,Mdm2和Mdmx也是HAUSP的真正底物。在本文中,我们综述了对泛素化调节p53肿瘤抑制途径的最新认识。

相似文献

1
Dissecting roles of ubiquitination in the p53 pathway.剖析泛素化在p53信号通路中的作用。
Ernst Schering Found Symp Proc. 2008(1):127-36. doi: 10.1007/2789_2008_105.
2
Dynamics in the p53-Mdm2 ubiquitination pathway.p53-Mdm2泛素化途径中的动力学
Cell Cycle. 2004 Jul;3(7):895-9. Epub 2004 Jul 2.
3
HAUSP as a therapeutic target for hematopoietic tumors (review).作为造血肿瘤治疗靶点的HAUSP(综述)
Int J Oncol. 2006 May;28(5):1209-15.
4
A dynamic role of HAUSP in the p53-Mdm2 pathway.HAUSP在p53-Mdm2通路中的动态作用。
Mol Cell. 2004 Mar 26;13(6):879-86. doi: 10.1016/s1097-2765(04)00157-1.
5
Modulation of the p53/MDM2 interplay by HAUSP inhibitors.HAUSP抑制剂对p53/MDM2相互作用的调节作用。
J Mol Cell Biol. 2017 Feb 1;9(1):45-52. doi: 10.1093/jmcb/mjw049.
6
p53 stability is regulated by diverse deubiquitinating enzymes.p53 的稳定性受多种去泛素化酶的调节。
Biochim Biophys Acta Rev Cancer. 2017 Dec;1868(2):404-411. doi: 10.1016/j.bbcan.2017.08.001. Epub 2017 Aug 8.
7
HAUSP-nucleolin interaction is regulated by p53-Mdm2 complex in response to DNA damage response.在DNA损伤反应中,HAUSP与核仁素的相互作用受p53-Mdm2复合物调控。
Sci Rep. 2015 Aug 4;5:12793. doi: 10.1038/srep12793.
8
p53 ubiquitination: Mdm2 and beyond.p53泛素化:Mdm2及其他相关蛋白
Mol Cell. 2006 Feb 3;21(3):307-15. doi: 10.1016/j.molcel.2006.01.020.
9
HLA-B-associated transcript 3 (Bat3) stabilizes and activates p53 in a HAUSP-dependent manner.HLA-B 相关转录物 3(Bat3)以 HAUSP 依赖性方式稳定并激活 p53。
J Mol Cell Biol. 2020 Feb 20;12(2):99-112. doi: 10.1093/jmcb/mjz102.
10
Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization.HAUSP对p53的去泛素化是p53稳定化的重要途径。
Nature. 2002 Apr 11;416(6881):648-53. doi: 10.1038/nature737. Epub 2002 Mar 31.

引用本文的文献

1
Targeting the p53 signaling pathway in cancers: Molecular mechanisms and clinical studies.癌症中靶向p53信号通路:分子机制与临床研究
MedComm (2020). 2023 May 28;4(3):e288. doi: 10.1002/mco2.288. eCollection 2023 Jun.
2
Regulators of Oncogenic Mutant TP53 Gain of Function.致癌突变型TP53功能获得的调控因子。
Cancers (Basel). 2018 Dec 20;11(1):4. doi: 10.3390/cancers11010004.
3
Hydrophobic Patch of Ubiquitin is Important for its Optimal Activation by Ubiquitin Activating Enzyme E1.泛素的疏水区对于泛素激活酶 E1 的最佳激活很重要。
Anal Chem. 2017 Aug 1;89(15):7852-7860. doi: 10.1021/acs.analchem.6b04194. Epub 2017 Jul 20.
4
Genetic Variations in the TP53 Pathway in Native Americans Strongly Suggest Adaptation to the High Altitudes of the Andes.美洲原住民TP53通路中的基因变异强烈表明其对安第斯山脉高海拔环境的适应性。
PLoS One. 2015 Sep 18;10(9):e0137823. doi: 10.1371/journal.pone.0137823. eCollection 2015.
5
The TP53 fertility network.TP53 生育网络。
Genet Mol Biol. 2012 Dec;35(4 (suppl)):939-46. doi: 10.1590/s1415-47572012000600008. Epub 2012 Dec 18.
6
Roles of HAUSP-mediated p53 regulation in central nervous system development.HAUSP 介导的 p53 调控在中枢神经系统发育中的作用。
Cell Death Differ. 2011 Aug;18(8):1366-75. doi: 10.1038/cdd.2011.12. Epub 2011 Feb 25.
7
The herpesvirus associated ubiquitin specific protease, USP7, is a negative regulator of PML proteins and PML nuclear bodies.疱疹病毒相关泛素特异性蛋白酶 USP7 是 PML 蛋白和 PML 核体的负调节剂。
PLoS One. 2011 Jan 31;6(1):e16598. doi: 10.1371/journal.pone.0016598.
8
The p53 pathway as a target in cancer therapeutics: obstacles and promise.p53 通路作为癌症治疗靶点:障碍与前景。
Sci Transl Med. 2011 Jan 5;3(64):64rv1. doi: 10.1126/scitranslmed.3001366.
9
Regulation of Abro1/KIAA0157 during myocardial infarction and cell death reveals a novel cardioprotective mechanism for Lys63-specific deubiquitination.心肌梗死和细胞死亡过程中 Abro1/KIAA0157 的调控揭示了 Lys63 特异性去泛素化的一种新的心脏保护机制。
J Mol Cell Cardiol. 2011 Apr;50(4):652-61. doi: 10.1016/j.yjmcc.2010.12.015. Epub 2010 Dec 30.
10
USP7/HAUSP promotes the sequence-specific DNA binding activity of p53.USP7/HAUSP 促进 p53 的序列特异性 DNA 结合活性。
PLoS One. 2010 Sep 27;5(9):e13040. doi: 10.1371/journal.pone.0013040.